NMT Medical Announces 2001 Annual Meeting of Stockholders

Apr 17, 2001, 01:00 ET from NMT Medical, Inc.

    BOSTON, April 17 /PRNewswire/ -- NMT Medical, Inc., (Nasdaq:   NMTI)
 announced tod4ay that its 2001 Annual Meeting of Stockholders will be held on
 Thursday, June 7, 2001, commencing at 1:30 p.m., local time, at the Company's
 offices at 27 Wormwood Street, Boston, Massachusetts 02210-1625.  Stockholders
 of record at the close of business on April 23, 2001 are entitled to notice of
 and to vote at the meeting (or any adjournment of the meeting).
     Because the 2001 Annual Meeting date has been changed by more than 30
 calendar days from the date of the Company's 2000 Annual Meeting of
 Stockholders, which was held on August 18, 2000, the Company is hereby
 informing its stockholders of the 2001 Annual Meeting date in addition to the
 following new deadlines for submitting stockholder proposals for the meeting:
 
      -- stockholder proposals intended to be presented at the meeting and
         considered for inclusion in the proxy statement must be received by
         the Company at its principal offices, 27 Wormwood Street, Boston,
         Massachusetts 02210-1625 by April 23, 2001; and
 
      -- a stockholder of the Company who wishes to present a proposal before
         the meeting but does not wish the proposal to be considered for
         inclusion in the Company's proxy statement and proxy card, must give
         written notice to the Secretary of the Company at the address noted
         above by April 27, 2001.  If a stockholder fails to provide timely
         notice of such a proposal, the proxies designated by the Board of
         Directors of the Company will have discretionary authority to vote on
         the proposal.
 
     The Company expects to mail its Annual Report to Stockholders for the year
 ended December 31, 2000, along with the Notice and Proxy Statement of the 2001
 Annual Meeting on or about April 30, 2001.
     NMT Medical designs, develops and markets innovative medical devices that
 utilize advanced technologies and are delivered by minimally invasive
 procedures.  The Company's products are designed to offer alternative
 approaches to existing complex treatments, thereby reducing patient trauma,
 shortening procedure, hospitalization and recovery times, and lowering overall
 treatment costs.  The Company's medical devices include self-expanding stents,
 vena cava filters and septal repair devices.  The NMT Neurosciences division
 serves the needs of neurosurgeons with a range of implantable and disposable
 products, including cerebral spinal fluid shunts, external drainage products,
 and the Spetzler(TM) Titanium Aneurysm Clip.
 
     To receive NMT Medical's latest news release and other corporate documents
 via FAX -- at no cost -- please dial 1-800-PRO-INFO.  Enter the Company's
 symbol NMTI.
 
 

SOURCE NMT Medical, Inc.
    BOSTON, April 17 /PRNewswire/ -- NMT Medical, Inc., (Nasdaq:   NMTI)
 announced tod4ay that its 2001 Annual Meeting of Stockholders will be held on
 Thursday, June 7, 2001, commencing at 1:30 p.m., local time, at the Company's
 offices at 27 Wormwood Street, Boston, Massachusetts 02210-1625.  Stockholders
 of record at the close of business on April 23, 2001 are entitled to notice of
 and to vote at the meeting (or any adjournment of the meeting).
     Because the 2001 Annual Meeting date has been changed by more than 30
 calendar days from the date of the Company's 2000 Annual Meeting of
 Stockholders, which was held on August 18, 2000, the Company is hereby
 informing its stockholders of the 2001 Annual Meeting date in addition to the
 following new deadlines for submitting stockholder proposals for the meeting:
 
      -- stockholder proposals intended to be presented at the meeting and
         considered for inclusion in the proxy statement must be received by
         the Company at its principal offices, 27 Wormwood Street, Boston,
         Massachusetts 02210-1625 by April 23, 2001; and
 
      -- a stockholder of the Company who wishes to present a proposal before
         the meeting but does not wish the proposal to be considered for
         inclusion in the Company's proxy statement and proxy card, must give
         written notice to the Secretary of the Company at the address noted
         above by April 27, 2001.  If a stockholder fails to provide timely
         notice of such a proposal, the proxies designated by the Board of
         Directors of the Company will have discretionary authority to vote on
         the proposal.
 
     The Company expects to mail its Annual Report to Stockholders for the year
 ended December 31, 2000, along with the Notice and Proxy Statement of the 2001
 Annual Meeting on or about April 30, 2001.
     NMT Medical designs, develops and markets innovative medical devices that
 utilize advanced technologies and are delivered by minimally invasive
 procedures.  The Company's products are designed to offer alternative
 approaches to existing complex treatments, thereby reducing patient trauma,
 shortening procedure, hospitalization and recovery times, and lowering overall
 treatment costs.  The Company's medical devices include self-expanding stents,
 vena cava filters and septal repair devices.  The NMT Neurosciences division
 serves the needs of neurosurgeons with a range of implantable and disposable
 products, including cerebral spinal fluid shunts, external drainage products,
 and the Spetzler(TM) Titanium Aneurysm Clip.
 
     To receive NMT Medical's latest news release and other corporate documents
 via FAX -- at no cost -- please dial 1-800-PRO-INFO.  Enter the Company's
 symbol NMTI.
 
 SOURCE  NMT Medical, Inc.